Atogepant

CAS No. 1374248-81-3

Atogepant ( MK-8031;AGN-241689 )

Catalog No. M11545 CAS No. 1374248-81-3

A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Atogepant
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine.
  • Description
    A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine.Migraine Phase 3 Clinical
  • Synonyms
    MK-8031;AGN-241689
  • Pathway
    GPCR/G Protein
  • Target
    CGRP Receptor
  • Recptor
    CGRP Receptor
  • Research Area
    Neurological Disease
  • Indication
    Migraine

Chemical Information

  • CAS Number
    1374248-81-3
  • Formula Weight
    603.53
  • Molecular Formula
    C29H23F6N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(C1=CN=C2C(C[C@@]3(C4=CC=CN=C4NC3=O)C2)=C1)N[C@@H]5C(N(CC(F)(F)F)[C@H](C)[C@H](C6=C(F)C=CC(F)=C6F)C5)=O
  • Chemical Name
    (3'S)-N-[(3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Calcitonin(salmon) A...

    Calcitonin(salmon) Acetate, a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.Oral Calcitonin salmon treatment dose-dependently attenuates fasting and non-fasted hyperglycaemia during the intervention period.

  • Calcitonin salmon

    Calcitonin salmon, a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause.

  • Atogepant

    A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine.